Wegovy® 2.4 mg is a once-weekly prescription injection delivered in a single-dose prefilled pen containing semaglutide, a GLP-1 receptor agonist used for chronic weight management in adults with obesity or overweight conditions who have at least one weight-related health condition. This is the maintenance dose and the highest approved strength in the Wegovy dosing schedule.
Wegovy works by mimicking the natural GLP-1 hormone, which plays a key role in appetite regulation and food intake. It acts on areas of the brain that control hunger, helping to reduce appetite, limit cravings, and increase feelings of fullness after meals, which supports sustained calorie reduction when combined with a reduced-calorie diet and regular physical activity.
The 2.4 mg single-dose pen is designed for once-weekly subcutaneous injection, with each pen used for one dose only and then safely discarded after use. It is not intended for daily or repeated dosing.
Wegovy is intended for long-term, medically supervised weight management and should be used as part of a comprehensive treatment plan that includes lifestyle changes.
Common side effects may include:
- Nausea
- Vomiting
- Diarrhea or constipation
- Abdominal pain or bloating
- Reduced appetite
- Fatigue or dizziness in some individuals
These effects may vary between individuals and are often more noticeable when starting treatment or after dose adjustments.
Always use exactly as prescribed by a healthcare professional and follow proper injection instructions.
Reviews
There are no reviews yet.